According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, there is a profound ongoing need for additional medications to control the signs and symptoms of juvenile idiopathic arthritis (JIA), despite the availability of several approved biologic disease-modifying antirheumatic drugs (biologics) (Abstract #1813).
Drew, a 65-year-old man from Connecticut, was diagnosed with a spinal dural arteriovenous fistula (SDAVF), which is a rare vascular malformation of the spinal cord that only affects 1 in every 200,000 people. SDAVFs are underdiagnosed because symptoms can be vague and mirror many other types of medical problems. If left untreated, SDAVFs can result in permanent spinal cord injury. Despite the uncommon diagnosis, a multidisciplinary care team from Nuvance Health, including primary care, neurology, radiology, and neurosurgery correctly and expeditiously identified and surgically treated Drew’s SDAVF.
Michael S. Bednar, MD, chief of hand surgery at Loyola University Medical Center and Professor of Orthopaedic Surgery and Rehabilitation at Stritch School of Medicine has been named President-Elect of the American Board of Orthopaedic Surgery (ABOS).
Where bones fracture, surgeons often have to join the fragments with implants. Magnesium orthopaedic screws, which over time dissolve in the body, spare patients another operation after healing is completed and reduce the risk of infection. What happens inside the body during this process, though, is still largely unknown.
The five-year study, which will involve 40 diabetic women and 40 nondiabetic women, is expected to cost $2.7 million. Researcher hopes it will eventually free diabetic women from osteoporosis, one of many diseases that strike diabetics more forcefully than the general population.
The U.S. Department of Defense has awarded the University of Arkansas at Little Rock a $5.6 million grant to advance the NuCress™ scaffold, a groundbreaking bone regeneration technology. The NuCress™ scaffold is in the final stages of moving from the laboratory to the surgical theater, with potential future uses in both military and civilian hospitals. The new award from the DOD’s Joint Warfighter Medical Research Program will help facilitate this transition by funding critical go-to-market research.
A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.
Unique clinical offering provides individualized treatment plans focused on evaluation of risk factors for osteoporosis and prevention strategies for avoiding bone loss and fractures
The U.S. Department of Defense recently awarded researchers from MetroHealth Medical Center and Case Western Reserve University more than $800,000 to study the experiences and needs of veterans and civilians who have suffered spinal cord injuries.
Joshua J. Jacobs, MD, William A. Hark, MD and Susanne G. Swift Professor and Chair of Orthopedic Surgery at Rush University Medical Center, has been elected as Vice President of the American Board of Orthopaedic Surgery (ABOS) for a one-year term.
Osteoarthritis can produce joint pain and stiffness sufficient to limit and even prohibit the performance of everyday tasks. It becomes more common with age, once it starts it typically gets worse and there’s no known cure. But there are therapies that can relieve pain and maintain joint function.
Contrary to popular belief, cartilage in human joints can repair itself through a process similar to that used by creatures such as salamanders and zebrafish to regenerate limbs, researchers at Duke Health found.
A new experimental growth factor therapy appears to prevent a worsening of osteoarthritis by increasing the thickness of cartilage in the knee joint and preventing further loss, according to results from an early clinical trial that were published today in the Journal of the American Medical Association.
Researchers performed a systematic review and meta-analysis of published data on the effect of electrical stimulation therapies on spinal fusion. They found significant improvement overall in the rates of bone fusion following a course of electrical stimulation in preclinical and clinical studies.
Researchers from the University of Notre Dame have identified a pair of proteins believed to be critical for spreading, or metastasizing, breast cancer to bone.
New approach may boost the bone repair impaired by old age or cancer treatment.
Researchers, using a method called genome-wide association study, have illuminated the genetic underpinnings of high serum urate, the blood condition that brings on gout.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right